What the modelling shows:

Because NICE’s evaluation of whether treatments are cost-effective does not consider benefits like full social and informal care costs, the current system may be unable to fully evaluate the value of a treatment to society.

Changes in annual cost of Alzheimer’s under the different treatment scenarios.

What it means:

Dementia costs the UK economy £26bn annually, with over 80% of this cost carried by social and informal care. An effective treatment might be able to help with this cost, but the current approach to evaluation may not capture that benefit. It is vital that we understand the full value of future treatments and ensure that informal and care costs are recognised as part of the assessment process.

What we are recommending:

  • The measures that reflect the full value of Alzheimer’s treatments for individuals and society need to be identified, including where there are gaps in the current data.

Thinking Differently: preparing today to implement future dementia treatments

Executive Summary

A snapshot of the treatments we analysed, the challenges we outlined and recommended actions included in the full report.

Read our blog

Keep up to date on the latest policy stories.